NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Minocycline


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Antibiotic may be new stroke treatment
2009 OCT 19 ... The antibiotic minocycline may revolutionize the treatment of strokes. A new study, published in the open access ...
Subject: BioMed Central
Price: $3.00
*
Data on heart attack detailed by researchers at University of Pittsburgh
2009 OCT 12 ... with cardiopulmonary bypass," investigators in the United States report. "Minocycline has been shown to be neuroprotective across a number of brain injury models via ...
Subject: Heart Attack
Price: $3.00
*
Findings from University of Toronto in hepatitis reported
2009 OCT 19 ... "Of the tetracyclines, minocycline is unique in causing a significant incidence of a lupus-like syndrome and autoimmune ...
Subject: Hepatitis
Price: $3.00
*
Gunma University, Medical Department publishes research in hypersensitivity
2009 OCT 12 ... hypersensitivity was assessed using von Frey filaments. The microglial inhibitor minocycline was intraperitoneally administered daily for either 3 or 7 days. Spinal microglial ...
Subject: Hypersensitivity
Price: $3.00
*
New anti-infectives study findings have been reported by B. Habibiasl and colleagues
2009 OCT 12 ... "In this study, we evaluated the effects of central administration of minocycline (a tetracycline derivative) and riluzole (an antiglutamatergic drug) on morphine-induced ...
Subject: Anti-Infectives
Price: $3.00
*
New hepatitis findings from J. Ramakrishna and co-researchers published
2009 OCT 12 ... "Over the years, a variety of abnormal immune reactions to minocycline have been reported including arthritis, systemic lupus erythematostis. and hepatitis. ...
Subject: Hepatitis
Price: $3.00
*
New life sciences study results from State University of New York, Department of Psychology described
2009 OCT 6 ... IL-1 mRNA and augmented IL-1 and CD14 expression provoked by footshock. Injection of minocycline, a putative microglial inhibitor, blocked the IL-1 response to footshock, while CD14 and ...
Subject: Life Sciences
Price: $3.00
*
New Parkinson disease research from S.A. Parashos and co-researchers described
2009 NOV 1 ... agents in PD. Participants were randomized into treatment groups: creatine (n = 67), minocycline (n = 66), coenzyme Q10(n = 71), GPI-1485 (n = 71), and placebo(n = 138). Time between ...
Subject: Parkinson Disease
Price: $3.00
*
New therapy study findings have been published by scientists at Fukuoka University
2009 NOV 1 ... Anti-Infectives, Brain Ischemia, Cerebral Infarction, Ischemia, Middle Cerebral Artery, Minocycline, Pharmaceuticals, Therapy, Treatment, Fukuoka University. This article was ...
Subject: Therapy
Price: $3.00
*
Recent findings in Alzheimer disease described by researchers from McGill University
2009 OCT 5 ... pro-NGF in amyloid-beta oligomer-injected rats. These parameters were corrected by minocycline treatment. Minocycline also diminished altered matrix ...
Subject: Alzheimer Disease
Price: $3.00
*
Reports outline neuropathic pain research from University of Nottingham
2009 NOV 1 ... of endocannabinoids in vitro." "Here, we investigate the effect of minocycline, an inhibitor of activated microglia, on levels of the endocannabinoids anandamide and ...
Subject: Neuropathic Pain
Price: $3.00
*
Research from Newcastle University yields new data on bullous pemphigoid
2009 NOV 23 ... the United Kingdom, "The aim of this study was to evaluate the therapeutic benefit of minocycline in mucous membrane pemphigoid (MMP) predominantly involving the oral cavity. A ...
Subject: Bullous Pemphigoid
Price: $3.00
*
Research from S. Ikegaya and co-authors in the area of antimicrobials published
2009 OCT 12 ... a human monocytic cell line, and compared the results with those for other macrolides, minocycline and ofloxacin," scientists in Fukui, Japan report. "In the presence of ...
Subject: Antimicrobials
Price: $3.00
*
Research on acute myelogenous leukemia reported by scientists at Kanazawa Medical University
2009 OCT 12 ... abscess aspirates. The fever and thigh pain disappeared after administration of ABK and minocycline hydrochloride (MINO), and the abscess completely disappeared with the oral ...
Subject: Acute Myelogenous Leukemia
Price: $3.00
*
Research on life sciences published by E.P. Tierney et al
2009 OCT 19 ... the face, chest, neck, and hands; melasma; poikiloderma of Civatte; nevus of Ota; scars; minocycline hyperpigmentation; telangiectatic matting; residual hemangioma; granuloma annulare; ...
Subject: Life Sciences
View Free
Daily News
Article
Researchers from University of Georgia detail findings in ischemia
2009 OCT 5 ... for acute ischemic stroke must be evaluated in the context of effective reperfusion. Minocycline is a neuroprotective agent that inhibits proteolytic enzymes and therefore could ...
Subject: Ischemia
Price: $3.00
*
Studies from Fourth Military Medical University in the area of life sciences described
2009 NOV 23 ... iNOS expression and dopaminergic neuronal injury were partly reverse. Pretreatment with minocycline (microglia activation inhibitor), Mn-induced activation of microglia and dopaminergic ...
Subject: Life Sciences
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login